Search clinical trials for: Patient with latent prostate cancer
Total 237904 results
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
Sunnybrook Health Sciences CentreCompletedLatent Cancer (Prostate)Canada
-
Chang Gung Memorial HospitalCompletedLatent Cancer Prostate
-
Clinique Mutualiste Chirurgicale de la LoireTerminated
-
Uppsala UniversitySahlgrenska University Hospital, Sweden; University Hospital, Umeå; Uppsala University... and other collaboratorsNot yet recruiting
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)Not yet recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer
-
Peking University Third HospitalBayerNot yet recruiting
-
Paul ViscuseNot yet recruitingMetastatic Prostate Cancer | Castrate Sensitive Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingMalignant Solid Neoplasm | Breast Carcinoma | Metastatic Prostate Carcinoma | Ovarian Carcinoma | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Pancreatic Exocrine Neoplasm | Stage IVB Prostate Cancer American Joint Committee on Cancer v8United States
-
First Affiliated Hospital of Chongqing Medical...RecruitingPSMA | Prostate Cancer Stage | SPECTChina
-
Fusion Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Robert Bok, MD, PhDNational Cancer Institute (NCI)Not yet recruitingProstate CancerUnited States
-
Peking University First HospitalNot yet recruiting
-
Mayo ClinicNot yet recruitingLocalized Prostate Carcinoma | Stage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruiting
-
AstraZenecaMerck Sharp & Dohme LLCRecruitingMetastatic Castration-resistant Prostate CancerGermany
-
Acerand Therapeutics (Shanghai) LimitedRecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Solid Tumor, AdultChina
-
The First Affiliated Hospital of Xiamen UniversityRecruitingMetastatic Castration-resistant Prostate Cancer, mCRPCChina
-
EDAP TMS S.A.Recruiting
-
M.D. Anderson Cancer CenterNot yet recruitingAdvanced Prostate CancerUnited States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Prostate Cancer | Therapy, Directly ObservedChina
-
Ashutosh Kumar TewariOncovir, Inc.RecruitingProstate Cancer Patients on Active SurveillanceUnited States
-
University Health Network, TorontoNot yet recruitingAdvanced Prostate CancerCanada
-
Nuvation Bio Inc.RecruitingPancreatic Cancer | Advanced Solid Tumor | HER2-negative Breast Cancer | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Platinum-resistant Ovarian Cancer (PROC)United States
-
Fondazione del Piemonte per l'OncologiaRecruiting
-
Ohio State University Comprehensive Cancer CenterPfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals AmericaNot yet recruitingProstate Adenocarcinoma | Stage IIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
Roswell Park Cancer InstituteRecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
UNICANCERBayerNot yet recruitingProstatic Cancer, Castration-Resistant
-
Alessa Therapeutics Inc.National Cancer Institute (NCI)Not yet recruitingProstate AdenocarcinomaUnited States
-
Copenhagen University Hospital at HerlevRecruitingProstate CancerDenmark
-
Peking Union Medical College HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
MediLink Therapeutics (Suzhou) Co., Ltd.RecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)China
-
ModeX Therapeutics, An OPKO Health CompanyNot yet recruitingCervical Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Prostate Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Colon Cancer | Thyroid Cancer | Renal Cancer | Biliary Tract Cancer | Hepatocellular Cancer | GastroEsophageal Cancer
-
Azienda Unità Sanitaria Locale Reggio EmiliaRecruitingRehabilitation | Metastatic Prostate Cancer (PCa) in ADTItaly
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingCervical Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Renal Pelvis Cancer | Urinary Bladder Neoplasm | Recurrent...United States
-
Yonsei UniversityRecruitingProstatic NeoplasmKorea, Republic of
-
Fred Hutchinson Cancer CenterPromiCell Therapeutics, Inc.Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
Umeå UniversityRecruitingBreast Cancer | Colorectal Cancer | Prostate CancerSweden
-
Region SkaneRecruiting
-
University of UtahRecruitingSmoldering Multiple MyelomaUnited States
-
Hospital of MacerataNot yet recruiting
-
Huashan HospitalRecruitingProstate Specific Membrane Antigen Positive Metastatic Prostate CancerChina
-
Changhai HospitalNot yet recruitingOligo-metastatic Prostate CarcinomaChina
-
Stichting European Myeloma NetworkPfizerRecruitingSmoldering Multiple MyelomaNetherlands, France, Italy, Finland, Greece, Norway
-
Acibadem UniversityRecruiting
-
Regeneron PharmaceuticalsNot yet recruitingMonoclonal Gammopathy of Undetermined Significance (MGUS) | Smoldering Multiple Myeloma (SMM)
-
Bivision Pharmaceuticals, Inc.Recruiting
-
Centre Georges Francois LeclercNot yet recruitingPatients With Metastatic Castration-resistant Prostate Cancer
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Not yet recruitingRelugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerStage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States